235 related articles for article (PubMed ID: 24842055)
1. Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes.
Gerö D; Szoleczky P; Chatzianastasiou A; Papapetropoulos A; Szabo C
Mol Med; 2014 Jul; 20(1):313-28. PubMed ID: 24842055
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
3. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
Tao R; Kim SH; Honbo N; Karliner JS; Alano CC
J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
[TBL] [Abstract][Full Text] [Related]
4. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion.
Schriewer JM; Peek CB; Bass J; Schumacker PT
J Am Heart Assoc; 2013 Apr; 2(2):e000159. PubMed ID: 23598272
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation.
Erdélyi K; Bakondi E; Gergely P; Szabó C; Virág L
Cell Mol Life Sci; 2005 Apr; 62(7-8):751-9. PubMed ID: 15868400
[TBL] [Abstract][Full Text] [Related]
6. Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes.
Gero D; Szabo C
Br J Pharmacol; 2015 Oct; 172(20):4817-32. PubMed ID: 26218637
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
8. Poly (ADP-ribose) polymerase inhibition protects against myocardial ischaemia/reperfusion injury via suppressing mitophagy.
Cao S; Sun Y; Wang W; Wang B; Zhang Q; Pan C; Yuan Q; Xu F; Wei S; Chen Y
J Cell Mol Med; 2019 Oct; 23(10):6897-6906. PubMed ID: 31379115
[TBL] [Abstract][Full Text] [Related]
9. Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress.
Oláh G; Szczesny B; Brunyánszki A; López-García IA; Gerö D; Radák Z; Szabo C
PLoS One; 2015; 10(7):e0134227. PubMed ID: 26218895
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1.
Chen M; Zsengellér Z; Xiao CY; Szabó C
Cardiovasc Res; 2004 Sep; 63(4):682-8. PubMed ID: 15306224
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus 1 infection activates poly(ADP-ribose) polymerase and triggers the degradation of poly(ADP-ribose) glycohydrolase.
Grady SL; Hwang J; Vastag L; Rabinowitz JD; Shenk T
J Virol; 2012 Aug; 86(15):8259-68. PubMed ID: 22623791
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.
Pillai JB; Gupta M; Rajamohan SB; Lang R; Raman J; Gupta MP
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1545-53. PubMed ID: 16632544
[TBL] [Abstract][Full Text] [Related]
13. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury.
Szabó G; Bährle S
Curr Vasc Pharmacol; 2005 Jul; 3(3):215-20. PubMed ID: 16026318
[TBL] [Abstract][Full Text] [Related]
14. Ring finger protein 146/Iduna is a poly(ADP-ribose) polymer binding and PARsylation dependent E3 ubiquitin ligase.
Zhou ZD; Chan CH; Xiao ZC; Tan EK
Cell Adh Migr; 2011; 5(6):463-71. PubMed ID: 22274711
[TBL] [Abstract][Full Text] [Related]
15. Vincristine attenuates N-methyl-N'-nitro-N-nitrosoguanidine-induced poly-(ADP) ribose polymerase activity in cardiomyocytes.
Zhang J; Chatterjee K; Alano CC; Kalinowski MA; Honbo N; Karliner JS
J Cardiovasc Pharmacol; 2010 Mar; 55(3):219-26. PubMed ID: 20375713
[TBL] [Abstract][Full Text] [Related]
16. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
17. Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.
Poitras MF; Koh DW; Yu SW; Andrabi SA; Mandir AS; Poirier GG; Dawson VL; Dawson TM
Neuroscience; 2007 Aug; 148(1):198-211. PubMed ID: 17640816
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity.
Pillai JB; Isbatan A; Imai S; Gupta MP
J Biol Chem; 2005 Dec; 280(52):43121-30. PubMed ID: 16207712
[TBL] [Abstract][Full Text] [Related]
19. Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death.
Virág L; Szabó C
FASEB J; 2001 Jan; 15(1):99-107. PubMed ID: 11149897
[TBL] [Abstract][Full Text] [Related]
20. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
